• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年龄与女性乳腺癌预后呈U型关系:一项队列研究。

Age has a U-shaped relationship with breast cancer outcomes in women: a cohort study.

作者信息

Xie Yujie, Deng Yongqing, Wei Suosu, Huang Zhen, Li Lihui, Huang Kai, Wei Chunyu, Xu Jinan, Dong Lingguang, Zhang Qiuhuan, Zhao Jiehua, Zou Quanqing, Yang Jianrong

机构信息

Department of Breast and Thyroid Surgery, People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, China.

The Family Planning Office of Guangxi Academy of Medical Sciences and the People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, China.

出版信息

Front Oncol. 2023 Oct 4;13:1265304. doi: 10.3389/fonc.2023.1265304. eCollection 2023.

DOI:10.3389/fonc.2023.1265304
PMID:37860197
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10583555/
Abstract

BACKGROUND AND OBJECTIVES

Age is a significant determinant of susceptibility to breast cancer. Currently, the available evidence regarding the non-linear correlation between the age of diagnosis and the prognosis of breast cancer patients is contradictory. Insufficient data currently exist regarding the influence of age at diagnosis on the prognosis of breast cancer. The objective of our investigation was to examine the relationship between age at diagnosis and overall survival (OS), breast cancer-specific survival (BCSS), and disease-free survival (DFS).

METHODS

This retrospective cohort study included 1054 patients diagnosed with breast cancer between March 7, 2013 and December 31, 2019. The hazard ratios (HRs) and 95% confidence interval (CI) for OS, BCSS, DFS were assessed using Cox proportional hazard ratio models and restricted cubic splines (RCS).

RESULTS

The study included 1054 breast cancer patients who met the criteria. With a median follow-up of 4.86 years, 71 patients (6.74%) died and 144 patients (13.66%) relapsed. After multivariable adjustment, age showed a U-shaped association with OS, BCSS, and DFS, with significantly higher risk at two ends, with age inflection points of 44, 44, and 41 years for OS, BCSS, and DFS, respectively. For OS, Quartile 1 (HR, 2.09; 95% CI: 0.90-4.84), Quartile 3 (HR, 2.44; 95% CI: 1.05-5.65) and Quartile 4 (HR, 3.38; 95% CI: 1.51-7.54) had poorer OS compared with Quartile 2. Similar results were found for BCSS and DFS.

CONCLUSIONS

This study confirmed a U-shaped association between age at diagnosis and breast cancer outcome.

摘要

背景与目的

年龄是乳腺癌易感性的一个重要决定因素。目前,关于诊断年龄与乳腺癌患者预后之间非线性相关性的现有证据相互矛盾。目前关于诊断时年龄对乳腺癌预后影响的数据不足。我们研究的目的是探讨诊断时年龄与总生存期(OS)、乳腺癌特异性生存期(BCSS)和无病生存期(DFS)之间的关系。

方法

这项回顾性队列研究纳入了2013年3月7日至2019年12月31日期间确诊为乳腺癌的1054例患者。使用Cox比例风险模型和限制性立方样条(RCS)评估OS、BCSS、DFS的风险比(HRs)和95%置信区间(CI)。

结果

该研究纳入了1054例符合标准的乳腺癌患者。中位随访4.86年,71例患者(6.74%)死亡,144例患者(13.66%)复发。多变量调整后,年龄与OS、BCSS和DFS呈U形关联,两端风险显著更高,OS、BCSS和DFS的年龄拐点分别为44岁、44岁和41岁。对于OS,与第二四分位数相比,第一四分位数(HR,2.09;95%CI:0.90 - 4.84)、第三四分位数(HR,2.44;95%CI:1.05 - 5.65)和第四四分位数(HR,3.38;95%CI:1.51 - 7.54)的OS较差。BCSS和DFS也发现了类似结果。

结论

本研究证实了诊断时年龄与乳腺癌预后之间存在U形关联。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15c7/10583555/0a582dcac7ea/fonc-13-1265304-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15c7/10583555/f9ca3e172c9f/fonc-13-1265304-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15c7/10583555/05c64b75de1d/fonc-13-1265304-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15c7/10583555/0a582dcac7ea/fonc-13-1265304-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15c7/10583555/f9ca3e172c9f/fonc-13-1265304-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15c7/10583555/05c64b75de1d/fonc-13-1265304-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15c7/10583555/0a582dcac7ea/fonc-13-1265304-g003.jpg

相似文献

1
Age has a U-shaped relationship with breast cancer outcomes in women: a cohort study.年龄与女性乳腺癌预后呈U型关系:一项队列研究。
Front Oncol. 2023 Oct 4;13:1265304. doi: 10.3389/fonc.2023.1265304. eCollection 2023.
2
The relationship between women's body mass index and breast cancer outcomes was U-shaped.女性体重指数与乳腺癌预后之间的关系呈U形。
Front Oncol. 2023 May 25;13:1191093. doi: 10.3389/fonc.2023.1191093. eCollection 2023.
3
The impact of IGF-1R expression on the outcomes of patients with breast cancer: a meta-analysis.胰岛素样生长因子-1受体(IGF-1R)表达对乳腺癌患者预后的影响:一项荟萃分析。
Onco Targets Ther. 2015 Jan 29;8:279-87. doi: 10.2147/OTT.S74774. eCollection 2015.
4
Influence of age as a continuous variable on the prognosis of patients with pT1-2N1 breast cancer.年龄作为连续变量对 pT1-2N1 期乳腺癌患者预后的影响。
Breast. 2022 Dec;66:136-144. doi: 10.1016/j.breast.2022.08.005. Epub 2022 Aug 16.
5
Effect of Age on Breast Cancer Patient Prognoses: A Population-Based Study Using the SEER 18 Database.年龄对乳腺癌患者预后的影响:一项基于监测、流行病学和最终结果(SEER)18数据库的人群研究
PLoS One. 2016 Oct 31;11(10):e0165409. doi: 10.1371/journal.pone.0165409. eCollection 2016.
6
[Long-term recurrence rate and survival in different aged patients with breast cancer undergoing breast conserving therapy].[不同年龄乳腺癌患者保乳治疗后的长期复发率及生存率]
Zhonghua Wai Ke Za Zhi. 2021 Feb 1;59(2):127-133. doi: 10.3760/cma.j.cn112139-20200807-00617.
7
Tumor markers CA15-3, CA125, CEA and breast cancer survival by molecular subtype: a cohort study.肿瘤标志物CA15-3、CA125、癌胚抗原与分子亚型的乳腺癌生存率:一项队列研究
Breast Cancer. 2020 Jul;27(4):621-630. doi: 10.1007/s12282-020-01058-3. Epub 2020 Feb 10.
8
Ultrasound features for prediction of long-term outcomes of women with primary breast cancer <20 mm.超声特征对直径<20 mm原发性乳腺癌女性长期预后的预测作用
Front Oncol. 2023 Mar 16;13:1103397. doi: 10.3389/fonc.2023.1103397. eCollection 2023.
9
Evaluation of a beneficial effect of adjuvant chemotherapy in patients with stage I triple-negative breast cancer: a population-based study using the SEER 18 database.评价 SEER18 数据库中辅助化疗对 I 期三阴性乳腺癌患者的有益作用:一项基于人群的研究。
Breast Cancer Res Treat. 2020 Sep;183(2):429-438. doi: 10.1007/s10549-020-05776-2. Epub 2020 Jul 17.
10
Patients achieved pCR during neoadjuvant chemotherapy had better outcome than adjuvant chemotherapy setting in breast cancer: A comparative study.在乳腺癌中,新辅助化疗期间达到病理完全缓解的患者比辅助化疗的结局更好:一项比较研究。
Cancer Treat Res Commun. 2023;36:100719. doi: 10.1016/j.ctarc.2023.100719. Epub 2023 May 10.

引用本文的文献

1
Accelerated hazard prediction based on age time-scale for women diagnosed with breast cancer using a deep learning method.基于深度学习方法的女性乳腺癌患者年龄时间尺度加速风险预测。
BMC Med Inform Decis Mak. 2024 Oct 28;24(1):314. doi: 10.1186/s12911-024-02725-7.
2
Association Between Age and the 28-Day All-Cause Mortality in Tuberculosis Complicated by Sepsis in ICU Patients: A Retrospective Cohort Study.ICU中结核病合并脓毒症患者年龄与28天全因死亡率的关联:一项回顾性队列研究
Infect Drug Resist. 2024 May 10;17:1879-1892. doi: 10.2147/IDR.S455108. eCollection 2024.

本文引用的文献

1
Comparisons of Metastatic Patterns, Survival Outcomes and Tumor Immune Microenvironment Between Young and Non-Young Breast Cancer Patients.年轻与非年轻乳腺癌患者转移模式、生存结果及肿瘤免疫微环境的比较
Front Cell Dev Biol. 2022 Jul 14;10:923371. doi: 10.3389/fcell.2022.923371. eCollection 2022.
2
Association between age at initial diagnosis and post-metastasis mortality among women with recurrent metastatic breast cancer in China.中国复发性转移性乳腺癌女性中初始诊断年龄与转移后死亡之间的关系。
BMC Cancer. 2022 Apr 9;22(1):385. doi: 10.1186/s12885-022-09454-y.
3
The impact of young age (< 40 years) on the outcome of a cohort of patients with primary non-metastatic breast cancer: analysis of 10-year survival of a prospective study.
年轻(<40 岁)对原发性非转移性乳腺癌患者队列的预后的影响:一项前瞻性研究的 10 年生存分析。
BMC Cancer. 2022 Jan 3;22(1):27. doi: 10.1186/s12885-021-09100-z.
4
The impact of young age at diagnosis (age <40 years) on prognosis varies by breast cancer subtype: A U.S. SEER database analysis.诊断时年龄较轻(<40 岁)对预后的影响因乳腺癌亚型而异:美国 SEER 数据库分析。
Breast. 2022 Feb;61:77-83. doi: 10.1016/j.breast.2021.12.006. Epub 2021 Dec 13.
5
Effects of postmastectomy radiotherapy on survival in different age groups for patients with T3N0M0 breast cancer.保乳术后放疗对T3N0M0期乳腺癌患者不同年龄组生存率的影响。
Breast. 2021 Dec;60:247-254. doi: 10.1016/j.breast.2021.11.006. Epub 2021 Nov 16.
6
Differences in clinicopathological characteristics, treatment, and survival outcomes between older and younger breast cancer patients.老年与年轻乳腺癌患者的临床病理特征、治疗及生存结局差异。
Sci Rep. 2021 Jul 12;11(1):14340. doi: 10.1038/s41598-021-93676-w.
7
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
8
Priorities for the global advancement of care for older adults with cancer: an update of the International Society of Geriatric Oncology Priorities Initiative.全球推进老年癌症患者照护工作的重点:国际老年肿瘤学会优先事项倡议的最新进展。
Lancet Oncol. 2021 Jan;22(1):e29-e36. doi: 10.1016/S1470-2045(20)30473-3.
9
10-Year Breast Cancer Outcomes in Women ≤35 Years of Age.35岁及以下女性的10年乳腺癌预后
Int J Radiat Oncol Biol Phys. 2021 Mar 15;109(4):1007-1018. doi: 10.1016/j.ijrobp.2020.10.022. Epub 2020 Oct 24.
10
Breast cancer in the oldest old (≥ 89 years): Tumor characteristics, treatment choices, clinical outcomes and literature review.超高龄(≥89 岁)老年乳腺癌患者:肿瘤特征、治疗选择、临床结局及文献复习。
Eur J Surg Oncol. 2021 Apr;47(4):796-803. doi: 10.1016/j.ejso.2020.10.008. Epub 2020 Oct 13.